Goldman Sachs Group, Inc. (The) (GS) Insider Sells $2511208.99 in Stock

Feb 12, 2017, 00:53
Goldman Sachs Group, Inc. (The) (GS) Insider Sells $2511208.99 in Stock

Research analysts at Oppenheimer Holdings boosted their Q1 2017 earnings per share (EPS) estimates for Goldman Sachs Group in a research report issued to clients and investors on Wednesday. Finally, Atlantic Securities downgraded shares of Goldman Sachs Group, Inc. Oppenheimer Holdings analyst C. Kotowski now anticipates that the firm will earn $4.92 per share for the quarter, up from their prior forecast of $3.96. The EPS growth rate is projected at 86.94%. Comparatively, growth in the past five years was 9.66 percent (per annum). (The) (NYSE:GS) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC).

Zacksoffers analysts with an Average Broker Rating (or ABR), basing it on sell-side recommendations.

The Goldman Sachs Group, Inc.is now showing 17.8% EPS growth this year.

Returns and Valuations for The Goldman Sachs Group, Inc. The companys revenue was up 12.3% compared to the same quarter past year. Finally, CLSA reiterated an "outperform" rating and issued a $275.00 target price on shares of Goldman Sachs Group, Inc. RBC Capital Markets set a $170.00 price target on Goldman Sachs Group, Inc. (GS) ended last trading session with a change of 1.61 percent.

The firm has a market cap of $98.61 billion, a price-to-earnings ratio of 14.60 and a beta of 1.50. The share price of $241.55 is at a distance of 76.41 percent from its 52-week low and down -2.51 percent versus its peak. The stock is now moving above its 20-Day Simple Moving Average of 2.19% with the 50-Day Simple Moving Average of 2.19 percent. The Company Touched its 52-Week High on Jan 13, 2017 and 52-Week Low on Jun 27, 2016. The company maintains price to book ratio of 3.75 vs.an industry average at 4.28. For the Trailing twelve month period, company showed a Net Profit Margin of 24.17% and Return on Equity of the stock is 9.78%.

These Democratic Senators Took Up Reading Coretta Scott King's Letter
MSNBC adds, "The Senate voted along partisan lines, 49-43, to admonish Warren ". A number of Democratic senators threw their support behind Warren .

The relative strength index or RSI highlights overbought (above 70) and oversold (below 30) areas.

3 analysts rated the stock of AbbVie Inc. (The) from a "hold" rating to a "buy" rating and set a $184.00 price target for the company in a research report on Monday, October 17th. The stock gained a consensus recommendation of 2.22 on Zacks Investment Research where the scale runs from 1 to 5, 1 representing Strong buy and 5 showing Strong Sell. The highest and lowest price target given by the brokerage firms to the equity are $90 and $49, respectively. The company has a consensus rating of "Hold" and an average target price of $214.96. The stock has a 1-month performance of 3.64 percent and is 5.25 percent year-to-date as of the recent close. The Stock now has a Weekly Volatility of 1.85% and Monthly Volatility of 1.85%. Ngam Advisors L.P. now owns 140,243 shares of the investment management company's stock worth $20,837,000 after buying an additional 897 shares in the last quarter. Overweight rating was issued by 1 and Underweight rating was suggested by 0 Investors should trade with caution and watch out for further signals. Following the sale, the insider now owns 66,249 shares of the company's stock, valued at $15,561,227.61. BOKF NA now owns 40,885 shares of the investment management company's stock worth $6,593,000 after buying an additional 7,922 shares during the period. The company reported $5.08 EPS for the quarter, beating the analyst consensus estimate by $ 0.28. During the same period in the previous year, the business earned $4.68 earnings per share. The high end of the revenue guidance is $6.56 Billion and the low end is $6.38 Billion.

AbbVie Inc. (NYSE:ABBV) is expected to report revenue of $6.48 Billion for the current quarter, according to consensus estimate of 13 analysts.

AbbVie Inc.'s growth estimate for the current quarter is 9.6, and 9.5 percent for the next quarter. (NYSE:ABBV) for the next year 5 years is 14.38 percent (per annum), as compared to 18 percent (per annum) in the past 5 years.